scispace - formally typeset
S

Stephan Fichtlscherer

Researcher at Goethe University Frankfurt

Publications -  174
Citations -  15491

Stephan Fichtlscherer is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 28, co-authored 158 publications receiving 14601 citations. Previous affiliations of Stephan Fichtlscherer include University of Hamburg.

Papers
More filters
Journal ArticleDOI

Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

TL;DR: Patients with CAD revealed reduced levels and functional impairment of EPCs, which correlated with risk factors for CAD, and hypertension was identified as a major independent predictor for impaired EPC migration.
Journal ArticleDOI

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

TL;DR: It is demonstrated that statins potently augment endothelial progenitor cell differentiation in mononuclear cells and CD34-positive hematopoietic stem cells isolated from peripheral blood.
Journal ArticleDOI

Circulating MicroRNAs in Patients With Coronary Artery Disease

TL;DR: Circulating levels of vascular and inflammation-associated microRNAs are significantly downregulated in patients with coronary artery disease.
Journal ArticleDOI

Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events Proof of Concept for the Clinical Importance of Endogenous Vascular Repair

TL;DR: Reduced levels of circulating EPCs independently predict atherosclerotic disease progression, thus supporting an important role for endogenous vascular repair to modulate the clinical course of coronary artery disease.
Journal ArticleDOI

Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

TL;DR: A novel mechanism of action of statin treatment in patients with stable CAD is defined: the augmentation of circulating EPCs with enhanced functional activity.